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BACKGROUND: The parotid gland plays an integral part in digestion, immunity, and 
oral health. Parotid Secretory Protein (PSP, BPIFA2E) is an abundant protein that is 
secreted into the oral cavity. To understand the unique molecular mechanisms of sorting 
secretory proteins, structure must be studied. Protein structure is essential in 
understanding the basis of function.  
HYPOTHESIS:  We hypothesize that PSP in solution forms a dimer .  
METHODS: Initially, parotid secretory granules were purified from rat parotid glands 
by using differential centrifugation and crosslinked with formaldehyde. The products 
were analyzed by SDS-PAGE and Western blot for PSP. Using PCR technology our gene 
of interest (PSP) was fused with an epitope tag (V5 or HA). The PSP cDNA was also 
cloned in-frame with Gluthathione S-transferase (GST) in the pGEX 4T-3 vector. The 
GST-PSP fusion protein was expressed in BL21DE3 (p-LysE) bacteria. GST-PSP, or 
GST (control), was immobilized on glutathione sepharose resin. TNT reticulocyte lysates 
synthesized the PSP-V5 protein, and it was incubated with the immobilized GST-PSP. 
Analysis of bound PSP-V5 was done by Western blots probed with anti-V5 and anti-PSP 
antibodies. 
RESULTS: Formaldehyde crosslinking of parotid secretory granules created a new anti-
PSP immunoreactive species with twice the apparent size of PSP, suggesting 
v 
 
dimerization of PSP. An alternative approach used affinity binding of in vitro synthesized 
PSP. Anti-V5 western blot analysis shows repeatable binding of PSP-V5 to the GST-PSP 
resin, but little or no binding to the GST resin as a negative control. This indicates 
multimerization of PSP on the affinity column. Computational prediction of quaternary 
structure suggests two separate classes of PSP dimer models, either stacked or head-to-
head. PSP mutants were created by deleting possible dimer formation areas, and affinity 
binding experiments supported the head-to-head dimer model.  PSP mutants which 
cannot form dimers also cannot bind lipids.  
CONCLUSION: These experiments show PSP binding to itself as a dimer. This 
quarternary structure may be important for the function of PSP, such as binding to lipids. 
This groundwork will lay the foundation for the crystallization of PSP for future 
exploration.  Supported by NIH DE019243.   
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Salivary glands are an essential component to oral health [1]. There are three 
major salivary glands present bilaterally: submandibular, sublingual and parotid. They 
function to secrete saliva, which plays an important role in lubrication, buffering, 
remineralization, and digestion. The parotid gland is the largest of the three major 
salivary glands and has some unique properties as compared to the other glands. 
Approximately 60–65% of total saliva is produced by the parotid, 20–30% by the 
submandibular and 2–5% by the sublingual glands [2]. The parotid glands are purely 
serous and their secretion is watery and albuminous. The submandibular and sublingual 
glands are composed of mixed serous and mucous acini, and their secretions are thicker.  
Majority of our daily saliva comes from the parotid gland, which is imperative to daily 
human life and function. The content of the secretions of the parotid gland are amylase, 
Parotid Secretory Protein (PSP) and proline-rich proteins. All of these secretions possess 
antibacterial properties and are essential in host defense. If this gland is damaged, these 
proteins are lost as well as their functions.   
Individuals that have reduced salivary output experience oral dysfunction with 
normal daily activities such as speech, mastication, swallowing, taste and halitosis [3]. 
Decreased amounts of salivary flow can affect soft tissues leading to: epithelial atrophy, 
ulcerations and soreness, mucositis, and iatrogenic trauma [4]. In addition to these soft 
tissue changes, studies have shown hyposalivation can create suitable environments for 




secondary bacterial, fungal or viral infections.  Hard tissue complications can also result 
from low salivary flow. With decreased salivary flow, teeth are susceptible to fractures, 
dental caries and have an increased risk of microbial growth. A number of studies have 
shown the risks associated with losing salivary function. One study showed the number 
of decayed as well as decayed and filled root surfaces correlates with salivary microbial 
counts [6]. If saliva is more abundant there will be less decay as opposed to less saliva in 
which there would be more microbial counts and higher risk of caries. In addition to 
decay, prosthetic restorations can be quite challenging. Patients will lower amounts of 
saliva, that have difficulty combating infections often have issues tolerating partials and 
dentures due to dryness in the oral cavity.  This hyposalivation can create issues beyond 
the oral cavity, including esophageal dysfunction and aspiration pneumonia [7-9].  
Salivary glands can be damaged in a multitude of ways. More than 55,000 
Americans will develop cancer of the head and neck (most of which is preventable) this 
year; nearly 13,000 of them will die from it while the others live the rest of their lives 
trying to cope with the complications that arise from the treatments they receive. The oral 
cavity is highly susceptible to direct and indirect toxic effects of cancer chemotherapy 
and ionizing radiation [10]. This risk results from multiple factors, including high rates of 
cellular turnover for the lining mucosa, a diverse and complex microflora, and trauma to 
oral tissues during normal oral function [11]. Some oral complications of radiotherapy in 
the head and neck region are mucositis, loss of taste, osteoradionecrosis, radiation caries, 
and xerostomia [12]. Salivary glands have slow turnover rates of their cells and 




radiation exposure of as low as 2.5 Gy to the head and neck region of rats can cause 
significant long-term alterations in salivary gland function. 
For radiation patients, mucositis and taste loss is reversible, however xerostomia 
(dry mouth) related to damage from radiation exposure is irreversible. This symptom is 
caused by a decreased lubrication in the oral cavity, which is the result of radiation 
damage to salivary glands.  During radiation the glandular tissue changes composition 
and is gone once destroyed. Research has shown that the amount of exposure a salivary 
gland has to radiation correlates with the amount of tissue damage seen. In a post mortem 
human study done by Dreyer et al. [13] they assessed that in the lower dose range (<30 
Gy), damage is reversible to a certain extent, however, after a total dose of (>75 Gy) 
extensive degeneration of acini is found along with inflammation and fibrosis of the 
interstitium. Serous acinar cells appear to be more readily affected by irradiation than 
mucous acinar cells and ductal cells. There have been numerous studies using the rat 
model that show within three days after irradiation with a single dose of 15 Gy of x-rays, 
a decreased salivary flow of nearly 50% can be observed [14]. Copper et al. observed 
four phases in the radiation-induced loss of salivary gland function. The first phase (0-10 
days) is characterized by a rapid decline in flow rate without changes in amylase 
secretion or acinar cell number.  The second phase (10-60 days) includes a decrease in 
amylase secretion as well as acinar cell number which plateaus in the third stage. The 
fourth stage (120-240 days) shows further deterioration of gland function with very poor 
tissue morphology despite an increase in acinar cell number[15].  With both early and 
late responses to radiation, salivary gland tissue is the most frequently occurring side 




effects, which severely decrease a patient’s quality of life. In addition to a decrease in the 
quantity of saliva during radiotherapy, an unpleasant change in the consistency and 
composition of a patient’s saliva also occurs. After radiation, patient’s saliva gets rope-
like and viscous, leading to a decreased pH and buffering capacity. This results in altered 
immune and antibacterial properties that are necessary for good oral health.  There is a 
gradual oral flora shift seen in cancer patients due to acidogenic, cariogenic micro-
organisms that lead to increased risk of caries, periodontal disease as well as other oral 
manifestations.  A systematic review was done in the literature to update current 
understanding of how cancer therapies impact patient dental care. In the review of 64 
papers, the weighted overall prevalence of dental caries was 28.1%. They found that 
patients who were post-radiotherapy had the highest decayed, missing and filled teeth 
(DMFT) index of 17.1 vs healthy controls of 4.4 [16, 17]. The review also noted a higher 
presence of severe gingivitis than in normal healthy individuals.  
Salivary research has shown head and neck cancer radiation will decrease parotid 
gland volume and wipe out essential functions of the parotid salivary gland as well as 
alter parotid saliva consistency [18]. Treatment focus should be on optimized/new 
approaches to further reduce the dose to the parotids, and particularly submandibular and 
minor salivary glands, as these glands are major contributors to moistening of oral tissues 
[19]. All of these changes drastically change a patient’s quality of life, their ability to 
function and further prevent oral diseases.  
While the affects of radiotherapy for head and neck cancer greatly diminish saliva 
production, it does not come close to the number of people affected by Sjogren’s 




destroy the glands that produce tears and saliva. This disorder affects 1-4 million people 
in the US, most of which are more than 40 years old at the time of diagnosis. Women are 
9 times more likely to have Sjogren’s syndrome than men.  The hallmarks of this disorder 
are dry mouth and eyes. There is no cure for Sjogren’s and treatment is based on patient’s 
symptoms and quality of life. The severity of symptoms can vary from patient to patient. 
Often times Sjogren’s patients suffer from the same complications as head and neck 
cancer patients such as recurrent mouth infections, swollen parotid glands, hoarseness, 
difficulty swallowing and eating, as well as increased risk of caries and other dental 
issues.   
The goals of research on disorders such as Sjogren’s syndrome focus on 
increasing knowledge and understanding of the disorder, improving diagnostic 
techniques, and finding ways to treat, prevent and cure the disease. The United States 
Department of Health and Human Services has begun tracking the number of people 
affected by salivary gland dysfunction 
[http://www.ninds.nih.gov/disorders/sjogrens/sjogrens.htm]. National organizations are 
coming together to fund research programs specifically looking at the functional 
restoration of salivary glands. The goal of this funding is to encourage multidisciplinary 
studies focusing on restoring salivary gland function, including repair and regeneration of 
the host salivary gland, or replacement of a disease or damaged gland with a 
bioengineered gland.  
This current wave of research is looking at clinically and physiologically relevant 
treatments such as gene therapy to help patients not just cope with their complications but 




complex network of protein trafficking and secretion pathways in salivary gland cells. 
Once we have a firm understanding of protein sorting we can then design therapeutic 
proteins to fight systemic diseases [20].  
 
MECHANISM OF PAROTID GLAND SECRETION 
The parotid gland secretes copious amounts of specific proteins into the saliva.  
Salivary proteins include amylase, PSP, and Proline-Rich Proteins, and less abundant 
proteins such as histatin and statherin [21]. These three proteins are the most abundant 
luminal cargo proteins within the secretory granule. These proteins move through the 
trans-Golgi network along with hundreds of other proteins that are sorted into the correct 
pathway for secretion. Acinar cells, the functional unit of the parotid gland function as 
the regulatory center for synthesis and secretion of salivary proteins such as amylase and 
PSP. These secretory proteins are stored within secretory granules and participate in 
several pathways in the cell when induced by external and internal signals.  
 Due to the popularity of genetic engineering, salivary glands are becoming a target 
site for transgenes to be introduced to patients [22].  Secretion and sorting of proteins in 
the parotid, as with other exocrine cells, includes the (1) major regulated pathway, (2) 
minor regulated pathway, (3) apical and basolateral constitutive secretory pathways, and 
(4) constitutive-like secretory pathway [22]. Researchers are working on defining 
molecular interactions that affect sorting pathways in exocrine cells; however all the 
known mechanisms are not present in other cell types. In neuroendocrine and endocrine 
cells the pH of the secretory granules decrease during maturation from 6.2 at the trans 




is important for correct sorting and protein aggregation of certain cells [24]. In the parotid 
gland, the pH of the acinar cell granule increases from about pH 6.2 at the TGN to 6.8 or 
higher after maturation [25]. Furthermore, granule cargo proteins from parotid acinar 
cells (amylase and PSP) are unable to aggregate even in the presence of Ca++ and low 
pH, whereas pancreatic exocrine granule proteins (used as a control) aggregate in a 
fashion similar to endocrine cells [26].  This indicates that sorting of amylase and PSP in 
the parotid gland have some differences from endocrine cells that need to be studied.  
The parotid gland is an important study model in understanding regulation of 
secretory proteins. Out of all of the sorting mechanisms, parotid acinar cells have several 
regulated secretory pathways that secrete proteins in response to extracellular stimulation. 
The Regulated Secretion pathway is the main way in which secretory granules in 
exocrine cells are secreted, especially PSP.  They make up 80-90% of total protein 
secretion from parotid acinar cells [27].  This pathway targets the cargo proteins to the 
apical surface and into the oral cavity. Basal secretion is the other form of secretion that 
responds to extracellular stimulation but does not depend on it strongly. This secretion 
represents resting secretion of saliva between meals and the exocytosis from the minor 
regulated secretory pathway.  
Unlike the regulated secretion pathway, Constitutive Secretion represents the 
small continuous output of salivary proteins in the absence of stimulation. Analysis of 
unstimulated secretion from parotid tissue has identified three phases of unstimulated 
protein secretion [28]. The first phase constitutes proteins that appear to differ from 
granule proteins and may represent the constitutive secretory pathways in acinar cells or 




secretory pathway exists for the delivery of basolateral plasma membrane proteins and 
extracellular matrix components as well as being the only secretion that does not 
originate in the secretory granules but in the trans-Golgi network and ultimately ends up 
in the circulation. Much of the research in the past has been on apical secretion, however, 
learning about the basolateral secretory pathways in acinar cells might be helpful in our 
venture for discovering a cure for Sjogrens or limiting the devastating loss of parotid 
function in head and neck cancer patients. The goal of salivary glands producing and 
secreting therapeutic proteins from transgenes are vital for any of these clinical 
applications to exist.  
PAROTID SECRETORY PROTEIN 
 Parotid Secretory Protein (PSP) is a protein secreted from the parotid and 
sublingual salivary glands. PSP is known to have anti-bacterial, anti-viral, and anti-
inflammatory properties. PSP activity is of interest to compare to related proteins. 
Following the newly developed nomenclature [29] , rat PSP/BPIFA2E is a member of the 
PLUNCA subfamily of the BPI-fold superfamily [30]. The PLUNC locus on 
chromosome 20q11.21 has evolved through a series of gene duplication events ([31] , 
[32]). Analysis of these proteins has shown that their predicted structures are similar to 
that of lipopolysacharride (LPS)-binding protein (LBP) and bactericidal/permeability-
increasing protein (BPI), two essentially antagonistic, mammalian proteins critical in the 
mediation of signals from LPS. This similarity has led to speculation that the PLUNC 
family also have a host defense function. Whereas BPI is a product of inflammatory cells 
[33] and LBP is primarily produced within the liver [34], studies have previously shown 




respiratory tract [35]. The sites of SPLUNC1 expression correspond to locations where 
significant pathogenic loads are encountered and where bacterial sensing and/or 
neutralizing proteins might be required. 
Parotid Secretory Protein is one of the most abundant salivary proteins.  As a 
result of research done on PSP we know that it is important for sorting pathways in 
secretory granules of the parotid cell [27]. However, PSP function and structure is not 
known. Therefore, by understanding the structure of PSP, the mechanism of sorting of 
PSP can be understood .  
Studies by Venkatesh et al. conclude that amylase and PSP sorting have important 
differences [26].  Western blot analysis was done with independent purified samples and 
confirmed that PSP selectively bound to granule membranes, unlike amylase and Proline-
Rich Protein (PRP)[36]. When exogenous PSP was tested with digested granule 
membranes it still bound effectively, indicating that PSP does not require a protein 
receptor for binding to the membrane. This was not the case for exogenous amylase that 
was only found in the unbound fraction, emphasizing the specificity of PSP binding.  
The direct trafficking of parotid secretory protein is not well known. However, 
previous results show both bacterially expressed rat PSP and human PSP synthesized in 
vitro bind specifically to Phosphatidylinositol (3,4)Bisphosphate [36]. PSP bound to 
PI(3,4)P2 10-fold stronger than to PtdIns(3,5)P2 or PtdIns(4)P. The ability of PSP to 
decorate membranes suggests additional functions and may give us more insight as to 
how PSP is sorted and secreted. Therefore, we want to define all the protein interactions 
of PSP. The phosphorylated forms of phosphatidylinositol lipids typically function to 




bind specifically to PI(3,4)P2, either in liposome membranes or on lipid-overlay assays 
[37]. Other experiments suggest that this binding is important for interaction of PSP with 
secretory granule membranes. The ability of PSP to decorate membranes suggests 
additional functions, such as anchoring other proteins. However, in order to understand 
this binding and possible trafficking roles, defining the quaternary structure of PSP is 
vital. Preliminary crosslinking results suggest PSP may dimerize, which is the basis for 
this study. In this Masters Research project, one of the goals was to understand PSP 
quaternary structure. Structural modeling suggests several different dimer possibilities 
and it is our goal to provide experimental support suggesting whether one model is more 
likely.  The focused hypothesis for this work was that PSP forms a specific dimer as the 
quarternary structure. My results not only support a head-to-head PSP dimer model, but 




MATERIALS AND METHODS 
CLONE PRODUCTION - GST- FUSION PROTEINS  
In order to study the dimerization of PSP, it was important to produce a 
glutathione-S-transferase (GST) fusion protein. Fusion proteins are desirable because of 
the ease of affinity purification without denaturation.  Vectors such as pGEX 4T-3 
provide chemically induced and highly efficient expression of the GST-tagged 
recombinant PSP protein. This vector was used in E.coli as a C-terminal fusion with the 
26 kDa glutathione-S-transferase protein [38]. Rat PSP (rPSP) cDNA sequence was 
amplified by standard PCR. The primers used were dssBamPSPFor and rPSPEcoR1Rev 
(see Table 1 Primer Sequences). The PCR reaction was done using r-PSP-V5-6His-
pcDNA3.1 as the parent plasmid. The PCR conditions were optimized and samples were 
run at 95 for 10:00, followed by (94 for 0:45, 67 for 0:45, 72 for 2:00), repeated 30 
times, 72 for 10:00, and 4 for infinity.   
After PCR was complete, the amplified DNA was analyzed by agarose gel 
electrophoresis, and purified from the gel using the QIAQuick PCR Purification kit and 
then the QIAGEN QIAquick Gel Extraction Kit (following the manufacture’s protocol). 
The eluted DNA was digested with EcoRI and BamHI, using a serial digestion, with the 
first digestion reaction incubating all day, the second overnight. The ligation reaction was 
incubated over night at 16C, then transformed into DH5 cells via heat shock at 42 for 
30 seconds. Cells were rescued in standard Luria Broth (LB) and plated on ampicilan 




Wizard Plus SV Minipreps DNA Purification System (Promega Corporation, Madison, 
WI, USA). Throughout this project the DNA sequences of all clones were confirmed by 
both restriction enzyme digests and sequencing at the UofL CGeMM DNA Sequencing 
core before clones were used in experiments.   
 
CONSTRUCTION OF CLONES 
 
 The clones prepared for this work are listed in Table 1 and Figure 1. Each pGEX 
mutant was designed to express a GST fusion protein. All the clones were DNA 
sequenced to show correct reading frame and were then transformed into native BL21 
competent cells for protein expression.  
 
Table 1: List of the Expression Vector pGEX 4T-3 Clones for studying the dimerization 
of Parotid Secretory Protein  
 
INSERT TAG FINAL CLONE Protein Name 





No Insert None pGEX4T-3 GST 
Human-PSP deleted signal 
sequence 
None humPSPdss-pGEX4T-3 GST-dss-hPSP 
Rat-PSP deleted signal 
sequence, deleted N 
terminal 6 amino acids. 
None rPSPdss-SU6-pGEX4T-3 GST- rPSP-SU6 
Rat-PSP deleted signal 
sequence, deleted N 






















Figure 1: Plasmid map of pGEX-rPSP. 
 
 
Figure 1: Different PSP cDNA sequences were cloned into the pGEX expression vector. 
A GST empty vector was also made for a negative control. No V5 epitope tags were used 





The mutants expressed in a reticulocyte lysate are listed in Table 2.  
 
Table 2: Expression Vector pcDNA 6.2 clones for studying the expression and 
dimerization of Parotid Secretory Protein  
 
INSERT TAG FINAL CLONE Protein Name 
rat-PSPdss-V5[13], full 




C-terminus V5 tag, 9aa 
version, rat-PSPdss, stop 
codon to prevent reading 






sequence, stops after 107 
amino acids, includes attB 




rat-PSPdss, stops after 151 
amino acids, includes attB 




rat-PSPdss, stops after 
212amino acids, includes 







CAT provided by 
Invitrogen as a 
control.  
CAT-V5 
rat-PSP deleting the N 
terminus 39 amino acids, 
directly linked to the V5[13] 




rat-PSP deleting the N 
terminus 55 amino acids, 
directly linked to the V5[13] 




C-terminus V5[9] tag, rat-
PSP deleting the C terminus 
55 amino acids, and the N 
terminus 13 amino acids. 
Stop code inserted to 
prevent reading into the 













C-terminus V5[9] tag, rat-
PSP deleting the N terminus 
55 amino acids and the C 
terminus 6 amino acids. 
Stop code inserted to 
prevent reading into the 











TOPO VECTOR CLONING 
Invitrogen TOPO® cloning was used to make clones for studying the 
dimerization of PSP. The main element of TOPO is the enzyme DNA topoisomerase I, 
which functions both as a restriction enzyme and a ligase. Its biological role is to cleave 
and rejoin DNA during replication. Using PCR technology, the gene of interest (PSP) 
was fused with different epitope tags and cloned into a pcDNA 6.2 Gateway Directional 
TOPO vector. PCR reactions were done using Platinum PCR SuperMix High Fidelity 
from Invitrogen Corporation Carlsbad, CA. PCR conditions were optimized and are 
shown in Table 3:  
Table 3: TOPO Vector PCR Conditions  
Temperature Time (min) Cycle Repeated  
95 6:00 One time 
94 0:30 
10 times 60 0:30 
72 1:45 
94 0:30 
10 times 62 0:30 
72 1:45 
72 10:00 One time 
4   
 
 
The PCR amplification was confirmed by agarose gel electrophoresis. PCR fragment was 




resulting DNA was eluted with water, quantitated and set to ligate in a TOPO ligation 
reaction. Resultant ligation mix was transformed into TOP 10 DH5-. Minipreps were 
done on 11 colonies and several were confirmed by CORE Center at the University of 
Louisville. This DNA plasmid was then propagated in E. coli. These clones where then 
subcloned into the prokaryotic expression plasmids pGEX 4T-3 from GE Healthcare 
Bio-Sciences Corp (Piscataway, NJ) so as to maintain reading frames downstream to the 
inducible LacZ promoter, and adjacent to a fragment of the recombinant glutathione S-
transferase gene. GST-PSP fusion proteins were prepared from large scale bacterial 
cultures.  
 
GENE TAILOR MUTAGENESIS  
 The GeneTailor Site-Directed Mutagenesis System by Invitrogen Corporation 
Carlsbad, CA was used as the method to produce highly efficient in vitro site-directed 
mutagenesis. This system can generate base substitutions, deletions, or insertions of up to 
21 nucleotides in DNA plasmids of up to 8 kb from any source with no specialized 
vectors, host strains, or restriction sites required.  This system was used in the production 
of the point mutant PSP clones to study the hydrogen bonds within PSP. First the 
methylation reaction was done. For the mutagenesis reaction Platinum ® Pfx DNA 
Polymerase was used with 2 µl of methylation mixture per 50 µl of mutagenesis reaction 
was used. Parameters for the PCR were as in Table 4:  
Table 4:  Gene Tailor PCR conditions 
Temperature Time (min) Cycle Repeated  
94 2:00 One time 
94 0:30 
20 times 55 0:30 




68 10:00 One time 
4   
 
 
After the reaction, 10–20 µl of the product was analyzed on a 1% agarose gel. 
 
PURIFICATION OF FUSION PROTEIN  
 
Fresh LB culture (200 mL) was inoculated with the BL21DE3 cells harboring the 
GST-rPSP and the negative control GST (No PSP) clones and incubated at 37
o
C 
overnight. 15 mL of overnight culture was inoculated in fresh 100 mL LB medium and 
incubated until the absorbance at 600 nm reached 0.8. Protein expression was induced by 
0.1 mM IPTG and after two hours of incubation, cells were harvested by centrifugation at 
3750 rpm for 20 minutes. The pellet was washed and resuspended in 5 mL of PBS 
containing 1 mM PMSF and protease inhibitors. The Branson 150 Sonicator was used to 
disrupt the bacterial cells. Cells were sonicated for 10 seconds then put on ice for 10 
seconds and repeated 4 times.  The sonicated lysate was then centrifuged and bacterial 
supernatant was aliquoted into fresh 1.5 mL microcentrifuge tubes and stored at -80
o
C. 
Protein expression was quantified using biorad assay.  
PROTEIN ASSAY 
Bio-Rad Laboratories, Hercules, CA protein assays were used to test the protein 
production of each bacterial lysate. A BSA serial dilution was used to create a standard 
curve ranging from 120 µg/ml to 0.1 µg/ml. Each dilution had 10% sonication buffer to 
equalize all dilutions. Each fusion protein was diluted with the same dilution equivalent 
of maintaining a 10% sonication buffer solution.  On a 96 well plate, triplicate aliquots 




Victor 3 spectrophotometer. The readings were then analyzed using Microsoft Excel 
spreadsheet.  
ISOLATION OF PAROTID SECREORY GRANULES  
Parotid Secretory granules were purified from rat parotid glands by differential 
centrifugation. Rat parotid glands were homogenized in 0.285 mM sucrose -20 mM 
HEPES and then suspension centrifuged at 2020 x g. All centrifugations were preformed 
for 10 minutes. The supernatant was collected and centrifuged at 2884 x g. The pellet 
obtained was resuspended in sucrose buffer and centrifuged 1884 x g  followed by 
centrifugation of the obtained supernatant at 2884 x g to pellet the secretory granules. 
The granules were suspended in water,lysed by freeze-thaw, the suspension centrifuged 
at 18,000 x g and soluble cargo proteins separated from the granule membranes. The 
soluble fraction was used for crosslinking studies with Bst
3 
(Thermo Fisher Scientific Inc. 
Rockford, IL. Crosslinked products were analyzed by SDS-PAGE and western blots for 
amylase and PSP.  
CROSSLINKING METHOD 
The crosslinking procedure started with isolation of rat parotid granules, 
suspended in sucrose-HEPES [500 µl]. Then 1.4 l µl of 37% Formaldehyde was added to 
the tubes and incubated at room temperature for 2 minutes and 10 minutes. The control 
granules did not get formaldehyde. Next, 3.4 µl of 2M glycine (.75 g in 5 mls) was added 
to the tube and the reaction was quenched for 5 minutes. The tubes were then centrifuged 
at 3000 G for 10 minutes to bring down the granules. The supernatant was taken out and 
the granules were washed in 50 µl of sucrose-HEPES. Centrifugation was repeated for 10 




50 µl of sucrose-HEPES. An aliquote of 25 µl of sample was added to 25 µl of gel 
loading buffer with or without 2-Mercaptoethanol (βME) to corresponding tubes. All 
samples were heated in the hood for 5 minutes and then loaded onto SDS-PAGE and 
transferred by western blot and analyzed.  
AFFINTY BINDING EXPERIMENT PROTOCOL 
 
Glutathione sepharose 4B was obtained from GE Healthcare. The glutathione 
slurry was washed with cold, sterile, PBS, then centrifuged at 1000 x g for one minute. 
This was repeated a total of three times. The sonicated GST-fusion proteins from the -80 
freezer were thawed and equal amounts of protein (via BioRAD assay results) were place 
on 75 µl of glutathione sepharose resin.  GST-fusion proteins were then incubated with 
the resin for 1 hour at 4 C with mild agitation. After the incubation of the sonicated 
bacterial lysates on the resin it was washed six times with cold sterile PBS and spun at 
1000 x g for one minute. Resin was then resuspended with 500 µl of binding buffer 
(PBS). Then using the Promega TNT Translational Kit rPSP-V5 protein was synthesized 
and incubated with the immobilized GST-PSP fusion protein. Reticulocyte lysates were 
incubated for 90 minutes with agitation at room temperature. After binding was allowed 
to occur the resin beads were spun down and washed with PBS four times with binding 
buffer. 50 µl of 4X SDS-PAGE sample buffer was then added to the reaction tube and 
samples were boiled for five minutes. The supernatant was then loaded on to Invitrogen 
NuPAGE 4-12% Bis-Tris Gels 1.5mm x 10 well gel. The gel was run at constant 45 
mAmps. Bound proteins were then analyzed by western blots and probed with Invitrogen 
anti-V5 antibodies. These antibodies detected the PSP-V5 protein not the GST-PSP 




Chemiluminescent substrate from Thermo Scientific. The intensity of the bands or 
regions of binding were quantitated and compared from straight protein signal.    
COMPUTER MODELING OF QUATERNARY STRUCTURE 
 
The computer modeling program I-Tasser 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/) was used to model the PSP monomer 
structure. I-Tasser iteratively threads the PSP sequence through segmental comparisons 
to the large number of locally related gene sequences, and segments are compared to the 
Protein Structure Data Base (PDB) to identify optimal folds, and reassembled. 
SymmDock (http://bioinfo3d.cs.tau.ac.il/SymmDock/symmdock.html) was then used to 
identify two classes of significant PSP dimer models. SymmDock is an algorithm for 
prediction of complexes with Cn symmetry by geometry based docking.  For our PSP 
dimer models we see the C-terminal (or carboxy-terminal) tab crosses the line of 
symmetry and interacts with the opposite chain N-terminal alpha helix.    
Rosetta 3.4 docking protocol 
(https://www.rosettacommons.org/manuals/archive/rosetta3.4_user_guide/index.html) 
was used as another protein predictor model. This program does not make any 
assumptions on symmetry. With this program, it came up with the exact same head-to-
head dimer model strengthening our interest in explore this interaction.  
PROTEIN-LIPID BINDING  
A standard overlay protocol was used for testing protein binding to lipids. The 
first step was to bind lipids to the nitrocellulose membranes. Each membrane was spotted 
with 100 pmoles of phospatidylinositol (PtdIns) and with two forms of 




nitrocellulose membranes were blocked with 1% (w/v) non-fat milk in PBST [50 mM 
phosphate buffer, 150 mM sodium chloride (NaCl), and 0.1% (w/v) Tween-20] for 1 hour 
[39]. Next the PSP-V5 reticulocyte lysate protein was translated and incubated on the 
blocked membranes for 1 hour at room temperature. The membranes were washed 
thoroughly with PBST. The bound protein on the nitrocellulose membranes was detected 
by probing with Mouse monoclonal pk-1V5 primary antibody, and then  a Goat-Anti 
Mouse-HRP secondary antibody. The antibody signal was then picked up by a 
tetramenthylbenzidine (TMB) substrate kit (Thermo Scientific, Rockford, IL, USA) on a 





















FORMALDEHYDE CROSSLINKING WITH PAROTID SECRETORY GRANULES 
 
The goal of this experiment was to examine if native parotid secretory granules 
crosslink to other proteins. Using the crosslinking protocol from the method section, 
results showed native PSP protein crosslinked into a 45 kDa complex, twice the size of 
PSP. The negative controls showed no crosslinking of PSP protein. Concluding native 
PSP may form dimers to one another. 
Figure 2: Crosslinking Parotid Secretory Granules with Formaldehyde.  
 
 
Figure 2: Parotid secretory granules were isolated and cross-linked with formaldehyde. 
SDS-PAGE and western blots with antibodies specific for PSP were used to identify 
crosslinked complexes. The experiment showed PSP is crosslinked into a 45 kDa 




Additional PSP crosslinking studies were done testing the possible dimer 
formation with amylase. A different crosslinker Bst
3
 was used to compare the two cargo 
proteins. SDS-PAGE and western blots with antibodies specific for either PSP or amylase 
were used to identify crosslinked complexes. The cargo protein amylase did not crosslink 
at either concentration tested. The lack of complex formation by amylase shows that there 
is at least some level of specificity for formation of the PSP complex. I observed a 45 
kDa PSP complex at 0.025 mM Bst
3
, as compared to published methods using 0.1 – 1.0 
mM Bst
3
 [40, 41]. Crosslinking at low reagent concentrations is consistent with the 
presence of a stable complex. We found native PSP crosslinked into a 45kDa complex, 
twice the size of PSP, suggesting a dimer. Although we have a good indication of 
possible dimerization, a more defined system is needed, therefore we moved to affinity 














Figure 3: This experiment crosslinked native parotid granule cargo proteins using Bst
3
 
(1.0 or 0.1 mM). SDS-PAGE and western blots with antibodies specific for either PSP or 
amylase were used to identify crosslinked complexes. The cargo protein amylase did not 
crosslink at either concentration. Native PSP is crosslinked into a 45 kDa complex, twice 
the size of PSP, suggesting a dimer. The 45 kDa complex was observed even at very low 
concentrations of Bst
3





AFFINITY BINDING EXPERIMENTS 
The goal of the affinity binding is to directly test the possibility of PSP homo-
dimerization. First the GST-PSP fusion plasmid was made and expressed in bacterial 
cells. The bacterial lysates were quantified and incubated with glutathione sepharose 
beads for one hour allowing time for the GST-PSP fusion protein to bind to the bead. In 
conjunction with the bacterial lysates, rPSP-V5 was translated using reticulocyte lysate 
kits. The V5 epitope tag was used to specifically probe the reticulocyte lysate-translated 
protein. These lysates were incubated on to the glutathione affinity beads and incubated 
for one and a half hours. The resin beads were washed extensively with 5 ml of PBS five 
times.  Any bound proteins were striped off the beads by heating in β-mercaptoethanol 
sample buffer and run on an SDS-PAGE gel. Western blot transfer with an antibody 
probe for the V5 epitope tag showed repeated experiments of PSP dimer formation. 
Controls were done by using GST alone as a control bacterial lysate. Experiments varied 
on whether or not background was found in the binding experiments. The control 
reticulocyte lysate used, chloramphenicol acetyl-transferase (CAT), which is similar in 
size and tag as PSP was translated and incubated onto the glutathione affinity beads and 















Figure 4: This diagrams the major steps of the GST-PSP affinity binding experiments. 





















Figure 5: Shows the schematics of all GST bacterial lysate proteins that were used 
throughout the project in testing PSP dimerization. A, GST bacterial lysate with no PSP 
was used as the control resin in most of the experiments. B, GST-PSPdss bacterial lysate 
was used as our study lysate. C, GST-PSPdss SU13 bacterial lysates delete the necessary 












Figure 6: Reticulocyte Lysate PSP proteins.  
 
Figure 6: Illustrations of all the PSPs translated in reticulocyte lysates used in the 
experiments. Yellow stars represent the hydrogen bonding regions. Red rectangles 
represent V5 epitope tag used to probe the presence of protein on the western blot 
membrane. The last three clones represent the point mutations used to test the stacked 
model. Amino acids that had been identified to inhibit lipid binding were mutated to 
neutral or charged amino acids. R represents Arginine (+ charged); E represents Glutamic 




OPTMIZING AFFINITY BINDING EXPERIMENT 
Repeatability of Protocol 
Our first objective was to optimize the affinity binding experiment and test the 
dimerization of PSP.   Equal protein amounts of GST-PSP and GST bacterial lysates 
were incubated with glutathione beads to allow the GST to bind. The beads were washed 
and then incubated with 15 μl of rPSP-V5 programmed reticulocyte lysate. After 
incubation, beads were washed extensively. Any remaining bound proteins were stripped 
from the beads, run on an SDS-PAGE gel, and transferred to a nitrocellulose membrane 
by western blotting. The membrane was probed with anti-V5 antibody which can detect 
only the PSP-V5 and not the GST-PSP. The membrane was then developed with an HRP-
linked secondary antibody and the Pierce SuperSignal West Pico Chemiluminescent 
Substrate and the image in Figure 7 was captured on a Kodak ImageStation. The 
experiment was carried out using cold sterile PBS as our buffer. On the Kodak image, 
odd lanes represent GST-PSP bacterial lysate glutathione resin with the WT PSP-V5 
reticulocyte lysate bound. Lanes 2,4, and 6 contained GST (No PSP) resin with the same 
PSP-V5 reticulocyte lysate as our negative control. The gel load is the amount of PSP-V5 
lysate added to the GST-resin to compare to the amount bound, and verify protein 
expression using the TNT kits. In this experiment, there was a clear signal in the GST-
PSP resin lanes and a much weaker signal in the GST-resin (no PSP) lanes. Over 30% of 
the PSP-V5 bound to the GST-PSP resin (but little bound to the GST-resin). This 
experiment indicates that PSP (in PSP-V5) binds to the PSP in GST-PSP. In contrast, 




a dimer or higher multimer of PSP.  When we take into account the crosslinking 
experiments and the observed complex of 45 kDa, we infer that this is a dimer of PSP.   
 
 
Figure 7: Affinity binding of GST-PSP vs GST with rPSP-V5 reticulocyte lysate.  
 
 
Figure 7: Image of Western showing the affinity binding experiment in triplicate to test 
the protocol. Lanes 1,3, and 5 resin beads had GST-PSP protein bound. Columns for 
lanes 2,4, and 6 had GST resin. 20 ul of rPSP-V5 reticulocyte lysate was placed in each 
tube and allowed to incubate. After striping bound protein from the resin we found that 





Affinity Binding Buffer Optimization  
Our goal for this experiment was to optimize and ensure maximal binding activity using 
different buffers. To maximize binding, we tested four different buffers. Buffer 
concentrations were referenced from other studies using coupling buffers for similar 
experiments. All buffers were made on the same day. The specific contents of the buffers 
were as follows:    
Table 5: Affinity Binding Buffer Solutions 
Buffer Contents Results 
B1 
20 mM Tris [pH 7.4] 
 100 mM KCl 
0.1 mM EDTA 
Good binding 
B2 Cold, Sterile PBS Strong binding 
B3 
20 mM Tris [pH 7.4] 
 100 mM KCl 
 0.1 mM EDTA 
 0.05% Igepal CA-630, 
10%glycerol 
0.1 mM PMSF 
Very weak binding 
B4 
 
PBS, 1%  Igepal CA-630 
 2 mM DTT 




To test the buffers, GST-PSP bacterial lysate was bound to the glutathione beads. Parallel 
tubes were then washed with their respective buffers (B1 – B4). Next the translated PSP-
V5 in reticulocyte lysate was added and incubated. Finally the affinity binding beads 
were washed again with their respective buffers. The proteins were then stripped from the 
beads and run on an SDS-PAGE gel, transferred by western blotting to nitrocellulose 
membrane and then probed with the anti-V5 antibody. Results in Figure 8 show good 
binding with buffer 1, strong binding with buffer 2, and little to no binding with buffer 3 




termed Nonidet P40, or NP-40), a non-ionic detergent, disrupted binding between the 
bacterial GST-PSP and the PSP-V5.  Igepal CA-630 (Octylphenoxypolyethoxyethanol) is 
a phenol with a chain of repeating ethoxy groups, and a separate non-polar chain 
therefore, it has the capacity to disrupt both hydrogen bonds, and nonpolar interactions. 
Even low concentrations of Igepal CA-630 prevented binding of the PSP-V5 to the GST-
PSP, suggesting that PSP interaction involves hydrogen bonds, nonpolar interactions, or 
both.  We see strong translation of the rPSP-V5 reticulocyte lysate proteins, which is seen 
under the columns labeled gel load. The amount of protein binding under these gel load 
columns were about 30 % and 10% of what was put on the resin itself. This experimental 





Figure 8: Affinity Binding with Various Buffers.  
 
 
Figure 8: Binding of rPSPdss-V5 reticulocyte lysate on the GST-PSP resin was tested 
with 4 different buffers. Buffer compositions are listed in Table 5. Lanes 1-4 differed in 
buffer utilization. These lanes had the same GST-PSP bound to the resin and then rPSP-
V5 reticulocyte lysate bound. Buffer 1 (Lane 1) showed good binding. Buffer 2 (Lane 2) 
had the best binding result. Buffers 3 and 4 (Lanes 3&4) showed little to no binding. 
‘GEL LOAD’ (6 µl or 2 µl) is the volume of PSP-V5 lysate that was run on the gel to 




CONTROL EXPERIMENT WITH CHLORAMPHENICOL ACETYLTRANSFERASE 
(CAT) 
 
In the experiments above, an important negative control was the use of GST resin, which 
consistently showed minimal or no binding of PSP-V5.  However, we wanted to test 
another negative control that used the same GST-PSP resin. Chloramphenicol acetyl-
transferase (CAT) was chosen as a control protein because it has a similar size and 
isoelectric point (pI) as PSP. CAT molecular weight is 323 and the isoelectric point is 
5.9. PSP isoelectric point is 4.9. Both rPSP and CAT were cloned having a C-terminal V5 
epitope tag and were translated in rabbit reticulocyte lysates. In this experiment, shown in 
Figure 9, incubation of rat PSP-V5 with GST-PSP resin showed strong binding, with 
minimal background binding to GST.  
CAT-V5 reticulocyte lysate was incubated on the GST-PSP resin and results show no 
binding. Both reticulocyte lysates were also loaded directly on the gel and gave clear 
signals showing they were expressed and protein was made (load columns) resulting in 
the conclusion that CAT-V5 does not bind to the GST-PSP beads. This supports the 






Figure 9: Chloramphenicol acetyl-transferase (CAT) does not bind PSP.  
 
 
Figure 9: Results of the Chloramphenicol acetyl transferase (CAT) affinity binding 
experiment is show above. Lanes 1, 2, 5, and 6 have GST-PSP bacterial lysate bound to 
the resin. Lanes 3 and 4 have GST bound to the resin. Duplicate lanes were used with 
rPSP-V5 on both resins. CAT-V5 was incubated on the GST-PSP resin and results show 




TESTING HUMAN PSP  
 
The goal of this experiment was to test human PSP binding capabilities. We 
hypothesized the binding of human PSP would be similar to our rat PSP dimerization 
results. To carry out this experiment, human PSP cDNA was cloned into the pGEX 
vector, sequenced and then expressed in bacteria to create lysates with GST-hPSP. We 
also made a human PSP cDNA with a V5 epitope tag on the end (hPSP-V5) for 
translation in reticulocyte lysates. Using our affinity binding approach, we bound both 
GST-rPSP and GST-hPSP bacterial lysates separately to glutathione beads. Beads were 
washed, and then incubated with the respective human or rat PSP-V5 in reticulocyte 
lysates. After a thorough wash the products were eluted and run on an SDS-PAGE gel. 
The gel was transferred to a Western membrane and then probed with the same anti-V5 
antibody. Figure 10 shows the results of this experiment testing the rat model vs the 
human model. We see strong binding of our rat GST-PSP bacterial lysate to our rPSP-V5 
protein as well as strong binding of our human GST-PSP bacterial lysate with the human 
hPSP-V5 reticulocyte lysate. After repeated experiments of testing both human and rat 
PSP proteins side by side, we were able to conclude that human PSP interacts similarly to 




Figure 10: Affinity binding of Human PSP.  
 
Figure 10: Two different models were tested in this affinity binding experiment. The rat 
model proteins were run in lanes 1 and 2. In lanes 3 and 4 we used human PSP as the 
other model. Results from this experiment testing the two models side by side, show 
GST-PSP resin beads in both rat and human bound to the PSP reticulocyte lysate, 





TITRATION OF RPSP-V5 TO GLUTATHIONE SEPHAROSE BEADS  
 
Once the binding buffers were optimized, it was also important to test the amount of 
reticulocyte lysate needed for maximal dimerization.  The results of an experiment shown 
in Figure 11 illustrates 4 different amounts of PSP-V5 lysate added to both GST-PSP 
resin and control GST resin with no PSP. Results showed rPSP-V5 bound strongly to 
GST-PSP, with little binding to GST controls. After quantification of the intensities of 
the “regions of interest” (ROI) it also demonstrated that as the amount of rPSP-V5 
reticulocyte lysate was increased the binding intensity increased. The negative control 
resins gave a much lower level of binding intensity than the GST-PSP resins. Bound 
PSP-V5 was found to be maximized at 20 ul of PSP-V5 reticulocyte lysates with each 
dimerization experiment. There were experiments that tested larger amounts of 
reticulocyte lysate but did not increase the “region of interest” signal. With the amount of 
resin used in the experiment, 20 ul of reticulocyte lysate seemed to be the maximum 




Figure 11: PSP Reticulocyte Lysate Optimization.   
 
 
Figure 11: Lanes 1,3,5,7 had GST-PSP bound resin. Lanes 2,4,6,8 had the control GST 
bound resin. The amount of rPSP-V5 reticulocyte lysate added to the resin is labeled on 
the bottom of the image.  Both experimental and control resin got the same amount of 
lysate on the resin and were loaded next to one another. As the amount of reticulocyte 





Figure 12: Line Graph of GST-PSP binding vs GST Binding.  
 
Figure 12: Binding of PSP-V5 in reticulocyte lysate to GST-PSP (red squares) or GST 
resin (blue diamonds) showed that the GST resin had little to no avidity for the GST resin 
and a high specificity for the GST-PSP resin as you increase the amount of reticulocyte 
lysate.   
 Along with maximizing the amount of reticulocyte lysate used in the experiments, 
we wanted to compare the specificity of PSP-V5 binding to either GST-PSP, or GST 
alone as a control. By quantifying the ROI on the Kodak Imager we see the following 
results after graphing the data. Figure 12 confirms strong binding of rPSP-V5 to the GST-
PSP resin, and little to no binding to GST controls. As seen in the above figure, we also 
saw the continuing trend of increased intensity when we increased the amount of 
reticulocyte lysate added to the resin. 
 After seeing strong binding of rPSP-V5 to the GST-PSP resin, our goal was to 
quantify the percent of rPSP-V5 bond to the resin. The affinity binding experiment was 
carried out with triplicate lanes of GST alone and GST-PSP resin. 20 ul of reticulocyte 
lysate were incubated with the resin and after SDS-PAGE and western blot, the 




of rPSP-V5 to GST-PSP and minimal binding to the GST as a negative control. 
Quantification of this experiment was done on the Kodak image machine in which the 
band intensities (ROI) for this experiment were measured and show binding up to 80% of 
added rPSP-V5.  Similar results were obtained in 2 additional experiments.  
 
Figure 13: Percent rPSP-V5 bound to GST-PSP in Affinity binding.  
 
 
Figure 13: The percent of rPSP-V5 bound to the GST-PSP resin was examined in 
triplicate. Lanes 1-3 were negative controls with GST alone on the resin. Lanes 4-6 had 
GST-PSP immobilized on resin. Lanes 1-6 received 20 µl of rPSP-V5 reticulocyte lysate 
incubated on each column. Strong binding was found with the GST-PSP resin and little 
binding found on the GST resin. Lanes 7 and 9 contain the rare reticulocyte lysate to 




Figure 14: Bar Graph GST-PSP vs GST Percent Bound.  
 
 
Figure 14: In this figure it shows the amount of reticulocyte lysate bound to GST-PSP 
verses GST. As the bar graph shows the amount of PSP-V5 bound to the GST-PSP resin 
was significantly higher than the GST resin. Calculations from the ROI signal 
measurements show close to approximately 80% of PSP-V5 is being bound to the GST-





I-TASSER COMPUTER MODELING 
Using the I-Tasser program, a model was produced to represent the PSP monomer 
structure. Tertiary structure was based on I-Tasser for analysis of fold structure. I-Tasser 
iteratively threads the PSP sequence through thousands of segmental comparisons to a 
large number of locally related sequences, and segments are compared to the Protein 
Structure Data Base (PDB) to identify optimal folds, and reassembled.  Figure 15 shows 
the predicted PSP monomer structure. Broadly, it consists of an N-terminal alpha helix 
region (red), a series of beta-pleated sheets (green), and a C-terminal alpha helix. The 
model is a hollow tube and possesses a C-terminal tab that projects out at one end.  Both 
the N- and C-terminal regions are at the same end of the tube. Figure 16 shows the small 
variation among the PSP monomers however with each representation there are still two 





Figure 15: Monomer Structure of PSP.  
 
 
Figure 15: PSP secondary structure showing the alpha helix on the N and C terminal ends 




Figure 16: I-tasser PSP monomer models.   
RAT PSP 21-225 Monomer Models 
I-Tasser Model #1 
  
I-Tasser Model #2 
  






Figure 16: Different PSP monomer structures taken from I-Tasser. Each I-Tasser model 
is only very slightly different but still maintains the 2 alpha helixes and the beta-pleated 
sheet. The tertiary structure resembles a hollow tube structure, which resembles the 
structures of proteins in related family lineages.  
SYMMDOCK DIMERIZATION MODELS 
 SymmDock computer analysis program was used to predict dimer formation of 
PSP [http://bioinfo3d.cs.tau.ac.il/SymmDock/]. SymmDock is an algorithm for prediction 
of complexes with Cn symmetry by geometry-based docking [42, 43].  Results from this 
program show two major dimer classes with several variants of each depending on the 
rotation of the structure. The first dimer model of PSP was shown to form a crossed stack 
formation  (Figure 17).  This is similar to the proposed dimer of the Juvenile Hormone 
Binding protein (3AOE) [44], which has a similar monomer structure, but is only a 
distantly related protein.    The second PSP dimer model is an end-to-end dimer that 
nearly aligns the two tubes.  This is referred to as a head-to-head model (Figure 18). The 
ends of each tube that have the C-terminal tab interact. This dimer bears a close 
resemblance to the crystal structure of a monomer of BPI [29, 31],  a related protein that 




Figure 17: Symmdock prediction of stacked PSP dimer based on the I-tasser PSP 
monomer structure.  
 
Figure 17: The proposed stacked PSP dimer.  This dimer can vary based on the rotation 
of the two protein monomers.  
The most favorable I-tasser PSP monomer sequences were entered into 
SymmDock. Three head-to-head dimer models from SymmDock reported hydrogen 
bonding between the two monomer chains (they are highlighted in red) as well as the 




Figure 18A: SymmDock dimer predictions based on I-Tasser model #1. 
 
 
Figure 18A: The above figure is the most favored head-to-head model that was generated 
from the SymmDock program. This was the I-Tasser Model #1 and SymmDock model 
#3.  
Figure 18A is the preferred structure because 1) it has the most hydrogen bonds 
and therefore is likely the most stable, with a total of 13 between-chain bonds, 2) the 
model looks like BPI 3) structure was an output of two different computer programs (I-
Tasser & Rosetta) 
Table 6: Between chain hydrogen bonds for the head-to-head SymmDock #3 dimer based 
on I-Tasser model #1  
 
 DONOR ACCEPTOR Length 
1 B230 GLN N 52 SER O 2.83 
2 B229 GLY N 55 GLN OE1 2.86 
3 B230 GLN NE2 58 THR O 3.00 
4 B229 GLY N 58 THR OG1 2.79 
5 B229 GLY N 58 THR OG1 2.79 
6 B55 GLN NE2 227 LEU O 3.07 
7 230 GLN N B52 SER O 2.77 
8 229 GLY N B55 GLN OE1 2.79 
9 230 GLN NE2 B58 THR O 2.95 
10 229 GLY N B58 THR OG1 2.82 
11 229 GLN N B58 THR OG1 2.82 
12 47 ASN ND2 B151 THR O 3.19 
13 55 GLN NE2 B227 LEU O 3.07 
 
Table 6, shows hydrogen bonds that are assigned by NOC program and illustrates all of 




hydrogen bonds in the molecule. This head-to-head structure is strongly favored because 
it has the most inter-monomer reactions. The minimum bond length is 2.4 angstrom, the 
maximum length is 3.2 angstrom. The lengths of the bonds are all within normal limits.  
The two PSP monomers are labeled A and B.  In the table when referring to monomer A 
there is no alphabetical label, however monomer B shows a B in front of the site in which 
the bond is occurring. Importantly, note that all the interchain hydrogen bonds are 
between the C-terminal tab and then N-terminal helix.  
 
Figure 18B: SymmDock dimer prediction based on I-Tasser model #2. 
 
 
Figure 18B: The above figure is the twisted head-to-head model generated from I-tasser 
model #2 and SymmDock model #4. This figure only has eight hydrogen bonds between 
chains.  
Table 7: Between chain hydrogen bonds for the Head-to-head SymmDock #4 dimer 
based on I-Tasser model #2 
 DONOR ACCEPTOR Length 
1 B230 GLN NE2 65 SER OG 3.00 
2 B230 GLN NE2 65 SER OG 3.00 
3 B225 ASN ND2 221 GLY O 3.02 
4 B225 ASN ND2 225 ASN OD1 2.89 
5 230 GLN NE2 B65 SER OG 2.78 
6 230 GLN NE2 B65 SER OG 2.78 
7 225 ASN ND2 B221 GLY O 2.83 






Of these predictions of head-to-head PSP dimer models only the first (Fig 18A) has a 
strong resemblance to the related protein BPI structure which has already been 
crystallized and studied [45]. 
 Further enhancing our understanding of possible quaternary structures for the PSP 
dimer, the primary amino acid sequence was entered into the Rosetta Docking molecular 
modeling software. Rosetta is a library based object-oriented software suite, which 
provides a robust system for predicting and designing protein structures, protein folding 
mechanisms, and protein-protein interactions. The library contains the various tools that 
Rosetta uses, such as Atom, ResidueType, Residue, Conformation, Pose, ScoreFunction, 
and ScoreType. These components provide the data and services Rosetta uses to carry out 
its computations. The difference in this docking system is that it does not assume 
symmetry. The results from this software system showed the exact same head-to-head 
model which we obtained using the SymmDock software. These results added strength to 
that fact that the head-to-head model is the one of interest and the one we need to explore 









Figure 19: shows the Rosetta docking system (a) head-to-head model of the PSP dimer. 
This strengthens our dimer hypothesis and narrows down the orientation in which the 




Interestingly, Kolodziejczyk et al. have published a paper that compares the 
structure of Juvenile Hormone Binding Protein (JHBP) and its similarities to Human 
Lipid- Binding Protein. JHBP is a hormone carrier that has a large affect on insect 
development. It was shown that in the context of crystal packing, JHBP shows 
intermolecular B-sheet interactions that result in a dimer [47] that resembles that stacked 
version of our PSP dimer. Due to the close relationship of this molecule to the BPI family 
of which PSP is also a part, it makes sense for us to explore the stacked PSP dimer model 









Figure 20 shows two hydrophobic cavities within the core of JHBP and their accessibility 
in the context of crystal packing. a) shows the ribbon structure resembling the stacked 
model of PSP. b) shows two monomers of JHBP in which interactions of B-sheets are 





It is due to the resemblance and common nature of PSP to the BPI family proteins 
as well as two different computer modeling programs in which we observed that PSP 
may form a dimer two possible ways. One way being the head-to-head model that 
resembles the BPI super-family protein. The other being the stacked model, which both 
computer modeling systems show is a possibility. It was due to these findings that we set 
out to test these two models.  
 




Figure 21: I-Tasser computer analysis shows the stacked PSP dimer model shown to the 
left. On the right the head-to-head dimer model shows the C-terminal tabs interacting to 




TESTING PSP STACKED DIMER MODEL WITH PSP MUTANTS 
 
A set of mutants was made to test the stacked PSP dimer model that was predicted 
by SymmDock. Quaternary structure of a dimer is typically stabilized by hydrogen 
bonding between polar R-groups, ionic bonds between charged R-groups, hydrophobic 
interactions between nonpolar R-groups, and disulfide bonds. The surface of the PSP 
protein has local regions of polar, charged, or non-polar amino acid R-groups which may 
help stabilize a stacked dimer.  We tested the effect of mutation of four basic amino acid 
residues at the surface of PSP on the ability of PSP to form homodimers. Mutation of the 
basic residues could disrupt ionic bonds that stabilize the dimer, and mutation of the 
charges would likely disrupt the charge distribution across the surface of PSP.  Either of 




Figure 22: PSP Protein Mutan39ts and Truncations.  
 
Figure 22: The sequences of rat and mouse PSP are aligned. In order to define which 
dimer model PSP resembles, point mutations of basic amino acids were introduced into 
rat PSP, as shown in blue bold beneath the wild type sequence. Theses point mutations 
were found to be important for binding to lipids. In addition, N-terminal or C-terminal 
deletions (shown by bent arrows) were made for studying the dimerization of the end-to-
end dimer model. The dark blue is the attB part of Gateway cloning. The red is the V5 
tag. The lighter blue with astricks (*) represents a double mutant.  





Figure 23: Clones for rPSPdss mutants to test the stacked dimer model.  
 
Figure 23: shows a representation of PSP as a monomer having alpha-helixes at the 
beginning and end of the PSP sequence flanking beta pleated sheets.  Each of the clones 
has a V5 tag, allowing us to identify whether or not the protein was binding. Mutants A, 
B, and C possess amino acid changes displayed by the capital letters.  In PSP mutants A 
and B, the R amino acids were switched out to E’s. In PSP mutant C the R’s were 
changed into Q.  
 
The mutants shown in Figure 23 are important in that they are known to disrupt or 
inhibit lipid binding which could also possibly disrupt dimerization in the stacked model. 
To test these mutants, an affinity binding experiment was carried out initially with both 
GST-PSP and GST bacterial lysates incubated on to the glutathione resin. Resins were 
incubated with 20 µl of a particular rPSPdss mutant which was allowed to bind to the 
protein on the resin.   Experimental results show that none of the mutations inhibited 
binding of rPSPdss-V5 lysate on the GST-PSP resin. In each case there was little or no 





Figure 24: Affinity binding with PSP mutants testing stacked PSP dimer model. 
 
 
Figure 24: Mutants are labeled at the top of the figure. In the first three lanes GST-PSP 
bacterial lysate was on the resin bead in the last three lands GST was the protein on the 
resin bead. The mutants incubated with the GST-PSP protein were present after it was 
striped from the resin bead.  Mutants incubated with the GST protein showed little to no 
binding. The results of this experiment showed that the charged amino acids that 




TESTING PSP HEAD-TO-HEAD DIMER MODEL WITH PSP MUTANTS 
 The second PSP Dimer model interacts via the C-terminal (or carboxy-terminal) 
tab crossing the line of symmetry and interacts with the opposite chain N-terminal alpha 
helix.   This is the more intriguing model of the dimer due to its striking resemblance to 
the crystal structure of the BPI superfamily.  PSP is distinctly related to this bigger 
protein superfamily. Figure 25 shows the predicted hydrogen bonds thought to be 
essential for dimerization. It is from this model that we use varying clones to test this 
head-to-head dimer model by knocking out the 5 hydrogen bonds that are thought to 
participate in the dimer formation.  
 
Figure 25: Hydrogen bond modeling in the PSP head-to-head dimer.  
 
Figure 25, the PSP head-to-head dimer model has been rotated on its side to illustrate the 
predicted hydrogen bonds between the C-terminal tab of one PSP monomer with the N-




In order to study the head-to-head dimer models, several clones were made (Table 
2) and used to test this model. These models showed 5 hydrogen bonds that could 
possibly participate in the head-to-head dimer formation near by connecting the N and C 
terminals (Figure 25). To test this model, clones that possessed one, two or no hydrogen 
bonding regions were used. We found in our series of experiments that if areas for 
hydrogen bonding (whether there was one or two hydrogen bond sites) were present in 
the PSP sequence, binding would be seen with the GST-PSP resin, resembling a dimer. 
However if  no sites for hydrogen bonding are left in the reticulocyte lysate mutant PSP 
sequence,  represented by the V5-55ATG-PSP-13, results show no binding to the GST-
PSP resin protein. From these experiments we can determine that deletion of the 











Figure 26: Deletions were designed to test the importance of the predicted hydrogen 
bonds (stars). Full length GST-PSP was used on the resin to test binding of each 
reticulocyte lysate mutant shown above.  
 The first PSP sequence in Figure 26 shows the wild type (WT) PSP-V5 protein, 
having both N- and C-terminal hydrogen bond areas. When wild type goes onto the resin, 
strong binding is seen with GST-PSP resin and weak binding to GST alone. When the 
protein sequence becomes smaller on the N- terminal side, 39ATG-PSP-V5, but still 
possesses the hydrogen bond sites, results show binding to GST-PSP resin. If we delete 




binding to the GST-PSP resin remains. Similarly if we were to delete the C-terminal 
hydrogen bond sites and keep the N-terminal sites using mutant V5-PSP-13 binding to 
the GST-PSP resin remains. If both N- and C-terminal bond sites are absent, mutant V5-
55ATG-PSP-13, results show little to no binding to the GST-PSP resin, similar to the 
negative control GST resin. In conclusion, we can see that if there are hydrogen bond 
sites available, possible dimer formation can occur with the GST-PSP resin. However 
when all hydrogen bonds are absent from the mutant PSP there is no sign of dimerization 
with GST-PSP resin. These results show that both the N- and C-terminal hydrogen bond 
sites are essential to dimerization.   
DIMERIZATION AND LIPID BINDING 
 
There is strong evidence to support the idea that the presence or absences of 
hydrogen bonds from PSP monomers are vital to dimerization. It is also important to see 
whether these hydrogen bonds affect lipid binding. Using the same lipid binding protocol 
from the methods section several PSP clones were incubated to evaluate lipid binding. 
Specific lipids were spotted on nitrocellulose membranes and blocked with 1% non-fat 
milk in PBST [50mM phosphate buffer, 150 mM sodium chloride (NaCl), and 0.1% 
Tween-20] for 1 hour. After blocking the strips the membranes were incubated with 
different PSP clones translated in reticulocyte lysates in the same buffer. After an hour at 
room temperature, the membranes were then washed and protein was detected using anti-
PSP (1:10,000) followed by an anti-rabbit IgG (1:5,000). Signal solution was added and 
captured under a Kodak imaging machine. The lipid binding experiments were preformed 




Figure 27: Lipid Binding with PIP’s. 
 
 
Figure 27: On each membrane there are 3 lipids spotted on the membranes shown on the 
right in Figure 27. Membrane A was incubated with PSP clone PSP-Δ636-V5. Membrane 
B had clone rPSPdss-V5; Membrane C had clone V5-PSPdss- Δ13; Membrane D had M-
V5[9]-rPSPdss.  Both wild type PSPs show specific binding.  
Results show binding to lipids, particularly PI(3,4)P2,  on membranes of clone B 
and D.  Both proteins possess hydrogen bond sites available for dimerization.  This 
experiment also showed in membranes A and C, which had the protein mutations with 
hydrogen bonds absent on the C-terminal end that there was little to no binding of lipids. 
This further illustrated the potential importance of the hydrogen bond sites and 
overwhelming possibility of dimerization due to them. Figure 28 has the summary of the 




Figure 28:  Lipid Binding PSP Mutants. 
 
 
Figure 28: This cartoon illustrates PSP mutants that were translated with reticulocyte 
lysate and used to test lipid binding. The yellow star indicates the presences or absence of 




Figure 29: Results of Lipid Binding of PSP Mutants to PI(3,4)P2. 
 
Figure 29: This graph shows the results of the lipid binding studies with mutants to 
quantify the results with mutants that delete the N-terminal or C-terminal hydrogen 
binding areas. Bars are mean +/- SE of 2-4 experiments.      = P<0.01  = p<0.001 
compared to the WT PSP.  
Experiments indicate if WT PSP-V5 is translated and allowed to bind to lipids, it 
will bind PI(3,4)P2 strongly but not PI (control). If the C-terminal is deleted, removing 
the last 11 amino acids, we see binding of PI(3,4)P2 (termed PIP2).  However if we 
deleted just two more amino acids, which completely remove the C-terminal hydrogen 
bond area, we get a marked decrease in binding to lipid PI(3,4)P2. The same thing was 
observed if we delete the N-terminal hydrogen bond sites. PSP mutant 59ATG-PSP-V5 




no binding to PI(3,4)P2. This confirms the results in Figure 27 and reiterates the 







PAROTID SECRETORY PROTEIN 
 
Parotid Secretory Protein (PSP) is one of the major secreted proteins of both rat 
and human saliva. PSP is part of a sub-family called Palate, lung, nasal epithelium clone 
(PLUNC). The PLUNC genes are found within a 300 kb region of human chromosome 
20. Palate lung nasal epithelium clone (PLUNC) belongs to a group of proteins which 
include phospholipids transfer protein (PLTP), cholesterol ester transfer protein (CETP), 
bactericidal permeablility increasing protein (BPI), and LPS-binding protein (LBP). It is 
known these proteins play a critical role in host defense against bacteria and due to the 
homologous relationship with the PLUNC genes it suggests they may also play a role in 
immunity and host defense in the mouth, nose and upper airways.  
The PLUNC gene group was divided into short (SPLUNC1) and long 
(LPLUNC1) nomenclature based on structural similarities to BPI and protein length. Due 
to the increased complexity of this gene family, a new nomenclature was developed in 
which the new root symbol is BPIF# representing “BPI fold containing.” SPLUNC 
proteins having a short/single domain are now designated by BPIFA and LPLUNC 
proteins with two or long domains are named BPIFB. The specific name for PSP is 
BPIFA2. PSP is the human protein that is expressed in salivary glands and saliva. 
Research shows this protein induces agglutination of bacteria, having a powerful 




show this protein has many isoforms in different tissues meaning they could elicit 
different properties.  
Although the SPLUNC/PSP proteins are gaining more attention, there is still a lot 
to learn. Defining the mechanism of sorting of PSP will address our broad goal of 
understanding trafficking in the parotid gland. Extensive research has found that PSP 
binds lipids. However, before we are able to measure the binding affinity of PSP to lipids 
it is essential to know the quaternary structure of PSP.  We cannot begin to test function, 
without having a solid understanding of a protein’s form. Preliminary data suggests PSP 
may bind as a dimer opening up questions to PSP form. This is the basis for our research 
and the main goal of the thesis, to investigate the self-dimerization of PSP. We 
hypothesize that PSP forms a dimer. We later test our findings in structure and explored 
possible functions of PSP.  
To begin, with our hypothesis in mind, we expressed and purified PSP in 
Escherichia coli (E.coli). Using the Glutathione-S-transferase gene fusion system, we 
inserted rPSP cDNA into a pGEX vector, that was unidirectional and contained the 
Glutathione-S-transferase (GST) affinity tag. This allowed for easy purification of the 
protein from the bacterial lysate using glutathione sepharose resin.  An empty pGEX 
vector was also made to use as a negative control. In parallel with making a GST-fusion 
protein, reticulocyte lysates were made using the Promega TNT translational kit to 
translate rPSP with a V5 epitope tag on the end of it. These proteins were used in the 
affinity binding experiments used to test our hypothesis.  
Preliminary crosslinking data suggests PSP can dimerize, Crosslinking studies 




sucrose-HEPES buffer. Granules were then incubated at room temperature for 2 minutes 
with 0.1% Formaldehyde. Samples were boiled using SDS loading dye with βMCE and 
loaded onto a SDS-PAGE gel and transferred to a western membrane. Intact native PSP 
granules crosslinked into a 45 kDa complex, twice the size of PSP, suggesting 
dimerization. 
STRUCTURE OF PSP 
It is important to have a good understanding of structure so that we may better 
predict function. In order to studying possible dimerization of PSP, models were 
generated using computer model programs. We used a computer model program, I-
Tasser, to model the monomer structure of PSP. An amino acid sequence was submitted 
to the I-Tasser server and the resulting model of PSP showed several characteristics. The 
secondary structure has a series of beta-pleated sheets that are rolled into a long barrel 
shape. PSP also possesses three alpha helixes that run the length of the barrel. The 
monomer structure of PSP mirrors many of the short PLUNC proteins now know as 
BPIFA.  
Given the results of the crosslinking experiments, it gave us reason to use the 
monomer models of PSP, with an additional computer program to predict possible 
dimers. The program used was named SymmDock. The SymmDock algorithm program 
predicted sixteen different dimer models. Ten of the predictions were a stacked model 
formation and the other six were a head-to-head model. The head-to-head model seemed 
particularly interesting given the resemblance to long PLUNC group and the BPI 




dimer structure. We studied each predicted model and eliminated the likelihood of them 
based on our experiments as well as looking at bond formation.  
Using the PSP sequence we made proteins with mutations and truncations in 
different areas of the sequence. These truncations were known to disrupt and inhibit lipid 
binding. The stacked PSP dimer model has many configurations by just rotating one or 
both monomer models. If these mutations disrupted lipid binding they could have a 
significant affect on the formation of the dimer. Using the affinity binding protocol to test 
whether wild type (WT) PSP would bind to the mutation, we found binding in all three 
mutants. These results suggested that the charged amino acids that participate in lipid 
binding do not directly participate in dimer formation. Further, it shows that disrupting 
the charge and polarity pattern across the surface of PSP did not prevent dimerization. So 
we decided to focus our efforts on the head-to-head PSP dimer model.  
In the head-to-head model from SymmDock computer program, it shows that 
there are essential hydrogen bond sites possibly involved in the dimerizaion of PSP. 
These hydrogen bonds are located between the N and C-terminal ends of the PSP 
monomer. Several different PSP clones were constructed with deletions of one or both 
ends containing these hydrogen bond sites. The affinity binding protocol was used with 
WT GST-PSP on the resin and from our results we can conclude that both N and C-
terminal ends of the mutated PSP monomer translated in the reticulocyte lysate must be 
deleted in order to disrupt dimer formation. If you add back a single N or C terminal area 
with potential hydrogen binding sites you get dimerization formation with the WT PSP 
protein on the resin. After repeated experiments, our conclusion was that PSP dimerizes 




With the results of our experiments and the strength of our computer modeling, and the 
resemblance to BPI the evidence of PSP dimerizing is strong.  
Given the possibility PSP forming a dimer, we further explore the idea of 
function. There is not a lot of research on the function of PSP, however, we do know that 
PSP binds to Phosphatidylinositol (3,4)Bisphosphate [37]. Recent research also shows 
that PSP binds to the sugars of lipopolysaccarides (LPS) [48] and can reduce biofilms 
confirming antimicrobial activity.  With the understanding that PSP binds as a dimer we 
take a closer look at the different mutations of PSP and how it interacts with PIPs.  
Protein-overlay assays were used to quantify PSP binding to lipid membranes. 
First, lipid binding experiments were carried out by spotting lipids on the nitrocellulose 
membranes. The lipids strips were then blocked for one hour and later incubated with 20 
µLs of TNT reticulocyte lysate. Proteins were then washed and detected with primary 
and secondary antibodies.  
Rat PSP is 235 amino acids long; deletion of 13 amino acids from the C-terminus 
removed 3 predicted hydrogen bonds important for dimerization, and the resulting protein 
did not bind PtdIns(3,4)P2. Similarly, deletion of a group of hydrogen bonds near the N-
terminus disrupted both dimerization and binding to PtdIns(3,4)P2. Results show that 
PSP forms a homodimer in the lipid binding studies. In conclusion, not only have we 
found that PSP forms a dimer similar to BPI, but we showed binding of PSP to 
phosphatidylinositol 3,4-bisphosphate in lipid membranes is a specific interaction which 
requires dimerization. We suggest that this binding of PSP to secretory granule 
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